← Evidence map

ArticleCommunications medicine2023

Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients.

Junichiro Yuda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

47 papers cite it

2023
2024
2025
2026
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 37880389